Sino Medical Sciences Technology Inc. (SHA:688108)

SHA:688108 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	188.64	203.42	287.76	544.83
Cash & Short-Term Investments	224.94	188.64	203.42	287.76	544.83
Cash Growth	19.24%	-7.27%	-29.31%	-47.18%	-15.73%
Accounts Receivable	-	8.94	20.28	12	66.67
Other Receivables	-	0.49	0.53	0.86	0.7
Receivables	-	9.43	20.82	12.86	67.38
Inventory	-	118.22	98.13	84.88	64.75
Prepaid Expenses	-	1.83	2.6	-	-
Other Current Assets	-	26.06	29.94	45.3	46.48
Total Current Assets	-	344.18	354.9	430.8	723.43
Property, Plant & Equipment	-	165.95	176.77	172.58	139.16
Long-Term Investments	-	14	18.95	33.65	5
Goodwill	-	-	-	-	2.58
Other Intangible Assets	-	53.4	52.87	73.92	82.07
Long-Term Deferred Tax Assets	-	105.33	91.78	44.17	5.86
Long-Term Deferred Charges	-	375.91	369.2	333.07	253.06
Other Long-Term Assets	-	127.05	3.14	14.89	6.34
Total Assets	-	1,186	1,068	1,103	1,217
Accounts Payable	-	20.12	13.41	8.57	20.07
Accrued Expenses	-	57.65	62.19	55.18	63.38
Short-Term Debt	-	53.55	35.54	5.01	-
Current Portion of Long-Term Debt	-	0.76	-	-	-
Current Portion of Leases	-	14.96	10.95	11.78	-
Current Income Taxes Payable	-	-	-	-	0.13
Current Unearned Revenue	-	1.12	0.79	0.41	0.79
Other Current Liabilities	-	3.12	9.3	11.6	7.8
Total Current Liabilities	-	151.27	132.18	92.56	92.18
Long-Term Debt	-	105.3	-	-	-
Long-Term Leases	-	24.92	11.83	27.49	-
Long-Term Unearned Revenue	-	21	2	1.94	2.48
Long-Term Deferred Tax Liabilities	-	20.22	22.72	21.47	17.53
Other Long-Term Liabilities	-	1.46	11.4	14.47	27.44
Total Liabilities	-	324.17	180.13	157.92	139.63
Common Stock	-	410	410	410	410
Additional Paid-In Capital	-	608.92	596.87	527.37	545.23
Retained Earnings	-	-200.94	-161.31	-8.44	122.33
Comprehensive Income & Other	-	1.97	1.52	-1.09	0.31
Total Common Equity	857.51	819.96	847.08	927.84	1,078
Minority Interest	-	41.69	40.4	17.33	-
Shareholders' Equity	898.85	861.65	887.48	945.16	1,078
Total Liabilities & Equity	-	1,186	1,068	1,103	1,217
Total Debt	226.43	199.49	58.31	44.27	-
Net Cash (Debt)	-1.49	-10.85	145.11	243.48	544.83
Net Cash Growth	-	-	-40.40%	-55.31%	-15.73%
Net Cash Per Share	-0.00	-0.03	0.36	0.60	1.33
Filing Date Shares Outstanding	413.46	410	410	410	410
Total Common Shares Outstanding	413.46	410	410	410	410
Working Capital	-	192.9	222.72	338.24	631.26
Book Value Per Share	2.07	2.00	2.07	2.26	2.63
Tangible Book Value	600.22	766.55	794.21	853.92	993.22
Tangible Book Value Per Share	1.45	1.87	1.94	2.08	2.42
Machinery	-	286	278.74	226.45	179.29
Construction In Progress	-	1.55	6.66	11.92	40.94

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.